Insider Transactions in Q1 2025 at Revolution Medicines, Inc. (RVMD)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 01
2025
|
Mark A Goldsmith |
BUY
Grant, award, or other acquisition
|
Direct |
97,400
+17.69%
|
-
|
|
Mar 01
2025
|
Xiaolin Wang |
BUY
Grant, award, or other acquisition
|
Direct |
19,000
+15.32%
|
-
|
|
Mar 01
2025
|
Lin Wei Chief Medical Officer |
SELL
Grant, award, or other acquisition
|
Direct |
20,800
-18.5%
|
-
|
|
Mar 01
2025
|
Margaret A Horn Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
28,600
+15.44%
|
-
|
|
Mar 01
2025
|
Stephen Michael Kelsey |
BUY
Grant, award, or other acquisition
|
Direct |
36,600
+10.99%
|
-
|
|
Mar 01
2025
|
Jack Anders Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
20,400
+14.86%
|
-
|
|
Mar 01
2025
|
Jeff Cislini General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
22,000
+26.44%
|
-
|
|
Jan 21
2025
|
Jeff Cislini General Counsel |
SELL
Open market or private sale
|
Direct |
2,406
-5.78%
|
$96,240
$40.5 P/Share
|